tiprankstipranks
Trending News
More News >
Gain Therapeutics (GANX)
NASDAQ:GANX
US Market

Gain Therapeutics (GANX) Revenue

Compare
263 Followers

Gain Therapeutics Revenue

Gain Therapeutics had a revenue of 0.00 in the quarter ending Dec 31, 2024, with ―. This bring the company's revenue in the last twelve months to 0.00, Increased -100.00%. In the fiscal year ending Dec 31, 2024, Gain Therapeutics had annual revenue of 0.00 with -100.00% growth.
Revenue (ttm)
0.00
Revenue Growth
-100.00%
P/S Ratio
Infinity
Revenue/Employee
$0
Employees
23
Market Cap
$57.93M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
0.00-55.18K-100.00%
Dec 31, 2023
55.18K-84.93K-60.62%
Dec 31, 2022
140.11K-24.89K-15.08%
Dec 31, 2021
164.99K136.11K+471.29%
Dec 31, 2020
28.88K-12.42K-30.07%
Dec 31, 2019
41.30K20.69K+100.40%
Dec 31, 2018
20.61K
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis